PATIENT NAME : VIVEK KHANDELWAL 0000 PATIENT ID : VIVEM0000 ACCESSION NO : 0009OF035666 AGE : 35 Years SEX : Male DATE OF BIRTH : 10/07/1979 DRAWN : RECEIVED : 16/06/2015 17:37 REPORTED : 18/06/2015 12:37 REFERRING DOCTOR : SELF CLIENT PATIENT ID : Final Results Biological Reference Test Report Status Interval Units MICROSOFT COMPREHENSIVE HEALTH CHECKUP. DIRECT LDL CHOLESTEROL, SERUM DIRECT LDL CHOLESTEROL 147 100 129 Near or above optimal 130 159 Borderline High 160 189 High /= 190 Very High High mg/dL METHOD : SPECTROPHOTOMETRY Comments Non Fasting Package customer information Except for the first hours in the early morning, most individuals are in the non fasting state most of the time. The requirement for fasting, or the protocol of not eating or drinking anything for 8 to 12 hours before taking the test, sometimes becomes a restriction, and makes us avoid taking the test itself . A large number of investigations especially for the purpose of screening and prevention do not necessitate fasting before the collection of the sample and give relatively similar results when carried out non fasting. This health package has been designed keeping your convenience in mind and with a focus on the utility of the selected investigations in screening for commonly prevalent diseases. The tests which have been included in this package are for either of the following reasons: 1. Tests for which the already existing accepted protocol is either the non fasting or fasting state. 2. Tests whose efficacy is relatively unaffected when conducted non fasting. (Supported by studies and research papers) 3. One specific test (Triglyceride) has been included because of the growing body of research supporting the utility of post meal or non fasting triglyceride levels in being an independent marker for the risk of developing cardiovascular disease. 4. Tests which have a specific screening & preventive nature 5. Tests which have medical literature available which specifically supports either or all of the above Please Note: The reference ranges provided in your report are applicable only for fasting samples Standard texts describe non fasting as sample collection within 24 hours of the last meal Non fasting does not replace fasting as a necessary preparation for a large number of investigations and needs to be followed as directed by your physician or laboratory In case it is found that your sample is highly lipemic (milky) due to reasons ranging from genetic to dietary, the likelihood of some parameters necessitating an evaluation in a fasting condition at a later date is possible. * HIGH SENSITIVITY CREACTIVE PROTEIN HIGH SENSITIVITY CRP 11.30 Low risk for CAD: Average risk for CAD: 1.00 3.00 High risk for CAD: 3.00 High mg/L METHOD : NEPHELOMETRY TRIGLYCERIDES, NONFASTING, SERUM TRIGLYCERIDES, NONFASTING, SERUM 164 Not Established mg/dL METHOD : SPECTROPHOTOMETRY CREATININE, SERUM CREATININE 1.0 0.9 1.3 mg/dL METHOD : SPECTROPHOTOMETRY BLOOD UREA NITROGEN, SERUM Page 1 Of 4 C0000 MICROSOFT INDIA (R&D) PVT. LTD (MSIT) MICROSOFT CAMPUS, GACHIBOWLI, HYDERABAD 500032 ANDHRA PRADESH INDIA CLIENT CODE : CLIENT S NAME AND ADDRESS : Cert. No. M0137 SRL LIMITED SRL,REFERENCE LAB, GP26, MARUTI INDUSTRIAL ESTATE,UDYOG VIHAR,SECTOR18, GURGAON, 122015 HARYANA, INDIA Tel : 0000/ 0000, Fax : 0000 CIN U74899DL1995PLC070603 Email : YYYY@YYYY PATIENT NAME : VIVEK KHANDELWAL 0000 PATIENT ID : VIVEM0000 ACCESSION NO : 0009OF035666 AGE : 35 Years SEX : Male DATE OF BIRTH : 10/07/1979 DRAWN : RECEIVED : 16/06/2015 17:37 REPORTED : 18/06/2015 12:37 REFERRING DOCTOR : SELF CLIENT PATIENT ID : Final Results Biological Reference Test Report Status Interval Units BLOOD UREA NITROGEN 6 6 20 mg/dL METHOD : SPECTROPHOTOMETRY TOTAL PROTEIN, SERUM TOTAL PROTEIN 7.5 6.4 8.2 g/dL METHOD : SPECTROPHOTOMETRY BILIRUBIN, TOTAL, SERUM BILIRUBIN, TOTAL 0.40 0.00 1.00 mg/dL METHOD : SPECTROPHOTOMETRY ALANINE AMINOTRANSFERASE, SERUM ALANINE AMINOTRANSFERASE (ALT/SGPT) 47 16 63 U/L ASPARTATE AMINOTRANSFERASE, SERUM ASPARTATE AMINOTRANSFERASE (AST/SGOT) 20 15 37 U/L METHOD : SPECTROPHOTOMETRY GAMMA GLUTAMYL TRANSFERASE, SERUM GAMMA GLUTAMYL TRANSFERASE (GGT) 38 15 85 U/L METHOD : SPECTROPHOTOMETRY HEPATITIS B SURFACE ANTIGEN, SERUM HEPATITIS B SURFACE ANTIGEN NON REACTIVE NON REACTIVE METHOD : CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) PATIENT VALUE 0.03 or = 0.05 (Reactive) METHOD : CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) COMPLETE BLOOD COUNT, BLOOD RED BLOOD CELL COUNT 4.87 4.5 5.5 mil/μL METHOD : AUTOMATED HEMATOLOGY ANALYZER HEMOGLOBIN 14.5 13.0 17.0 g/dL METHOD : AUTOMATED HEMATOLOGY ANALYZER HEMATOCRIT 43.5 40 50 % METHOD : AUTOMATED HEMATOLOGY ANALYZER MEAN CORPUSCULAR VOLUME 89.3 83.0 101.0 fL METHOD : AUTOMATED HEMATOLOGY ANALYZER MEAN CORPUSCULAR HEMOGLOBIN 29.7 27.0 32.0 pg METHOD : AUTOMATED HEMATOLOGY ANALYZER MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION 33.3 31.5 34.5 g/dL METHOD : AUTOMATED HEMATOLOGY ANALYZER RED CELL DISTRIBUTION WIDTH 13.4 11.6 14.0 % METHOD : AUTOMATED HEMATOLOGY ANALYZER PLATELET COUNT 306 150 410 thou/μL METHOD : AUTOMATED ANALYSER, MICROSCOPY MEAN PLATELET VOLUME 9.5 6.8 10.9 fL Page 2 Of 4 C0000 MICROSOFT INDIA (R&D) PVT. LTD (MSIT) MICROSOFT CAMPUS, GACHIBOWLI, HYDERABAD 500032 ANDHRA PRADESH INDIA CLIENT CODE : CLIENT S NAME AND ADDRESS : Cert. No. M0137 SRL LIMITED SRL,REFERENCE LAB, GP26, MARUTI INDUSTRIAL ESTATE,UDYOG VIHAR,SECTOR18, GURGAON, 122015 HARYANA, INDIA Tel : 0000/ 0000, Fax : 0000 CIN U74899DL1995PLC070603 Email : YYYY@YYYY PATIENT NAME : VIVEK KHANDELWAL 0000 PATIENT ID : VIVEM0000 ACCESSION NO : 0009OF035666 AGE : 35 Years SEX : Male DATE OF BIRTH : 10/07/1979 DRAWN : RECEIVED : 16/06/2015 17:37 REPORTED : 18/06/2015 12:37 REFERRING DOCTOR : SELF CLIENT PATIENT ID : Final Results Biological Reference Test Report Status Interval Units METHOD : AUTOMATED HEMATOLOGY ANALYZER WHITE BLOOD CELL COUNT 8.3 4.0 10.0 thou/μL METHOD : AUTOMATED HEMATOLOGY ANALYZER WBC DIFFERENTIAL COUNT NEUTROPHILS 61 40 80 % METHOD : AUTOMATED ANALYSER, MICROSCOPY EOSINOPHILS 02 1 6 % METHOD : AUTOMATED ANALYSER, MICROSCOPY LYMPHOCYTES 32 20 40 % METHOD : AUTOMATED ANALYSER, MICROSCOPY MONOCYTES 05 2 10 % METHOD : AUTOMATED ANALYSER, MICROSCOPY BASOPHILS 00 % METHOD : AUTOMATED ANALYSER, MICROSCOPY DIFFERENTIAL COUNT PERFORMED ON: EDTA SMEAR METHOD : AUTOMATED ANALYSER, MICROSCOPY URINALYSIS COLOR PALE YELLOW APPEARANCE CLEAR PH 6.0 4.7 7.5 SPECIFIC GRAVITY 1.010 1.003 1.035 GLUCOSE NOT DETECTED NOT DETECTED PROTEIN NOT DETECTED NOT DETECTED KETONES NOT DETECTED NOT DETECTED BLOOD NOT DETECTED NOT DETECTED BILIRUBIN NOT DETECTED NOT DETECTED UROBILINOGEN NORMAL NORMAL NITRITE NOT DETECTED NOT DETECTED WBC 57 05 /HPF EPITHELIAL CELLS 12 05 /HPF RED BLOOD CELLS NOT DETECTED NOT DETECTED /HPF CASTS NOT DETECTED CRYSTALS NOT DETECTED BACTERIA NOT DETECTED NOT DETECTED Comments NOTE :MICROSCOPIC EXAMINATION OF URINE IS PERFORMED ON CENTRIFUGED URINARY SEDIMENT. * IN NORMAL URINE SAMPLES CAST AND CRYSTALS ARE NOT DETECTED. GLYCOSYLATED HEMOGLOBIN, EDTA WHOLE BLOOD GLYCOSYLATED HEMOGLOBIN (HBA1C) 5.8 Nondiabetic: Prediabetics: 5.7 6.4 High % Page 3 Of 4 C0000 MICROSOFT INDIA (R&D) PVT. LTD (MSIT) MICROSOFT CAMPUS, GACHIBOWLI, HYDERABAD 500032 ANDHRA PRADESH INDIA CLIENT CODE : CLIENT S NAME AND ADDRESS : Cert. No. M0137 SRL LIMITED SRL,REFERENCE LAB, GP26, MARUTI INDUSTRIAL ESTATE,UDYOG VIHAR,SECTOR18, GURGAON, 122015 HARYANA, INDIA Tel : 0000/ 0000, Fax : 0000 CIN U74899DL1995PLC070603 Email : YYYY@YYYY PATIENT NAME : VIVEK KHANDELWAL 0000 PATIENT ID : VIVEM0000 ACCESSION NO : 0009OF035666 AGE : 35 Years SEX : Male DATE OF BIRTH : 10/07/1979 DRAWN : RECEIVED : 16/06/2015 17:37 REPORTED : 18/06/2015 12:37 REFERRING DOCTOR : SELF CLIENT PATIENT ID : Final Results Biological Test Report Status Reference Interval Diabetics: or = 6.5 ADA Target: 7.0 Action suggested: 8.0 METHOD : HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MEAN PLASMA GLUCOSE 119.8 High TSH 3RD GENERATION ULTRA (TSH3 UL) TSH 3RD GENERATION 2.298 0.55 4.78 μIU/mL * LUNG FUNCTION TEST LUNG FUNCTION TEST NORMAL SPIROMETRY * BMI HEIGHT IN METERS 1.69 METRES WEIGHT IN KGS. 83 Kgs BMI 29.1 * BLOOD PRESSURE BLOOD PRESSURE 130/80 MM HG (SITTING) * ELECTROCARDIOGRAM ECG WITHIN NORMAL LIMITS Interpretation(s) TRIGLYCERIDES, NONFASTING, SERUMSpectrophotometry, Enzymatic GPO POD Method. CREATININE, SERUMTOTAL PROTEIN, SERUMALANINE AMINOTRANSFERASE, SERUMASPARTATE AMINOTRANSFERASE, SERUMCOMPLETE BLOOD COUNT, BLOODURINALYSISDipstick / microscopy GLYCOSYLATED HEMOGLOBIN, EDTA WHOLE BLOODHighPressure Liquid Chromatography (HPLC) TSH 3RD GENERATION ULTRA (TSH3 UL) Comment: The Biological Reference Interval of TSH3rd Generation Ultra [TSH3UL] is not established for age less than 2 years. Below mentioned are the guidelines for Pregnancy related reference ranges for TSH. Levels in TSH Pregnancy (μIU/mL) First Trimester 0.1 2.5 . 2nd Trimester 0.2 –3.0 . 3rd Trimester 0.3 –3.0 BMINormal BMI Range1822.9;Overweight 2324.9;Obese 25;Underweight ELECTROCARDIOGRAM‘ Wellnessconsultation for the above reports will be provided on select dates at your office location. In case you miss your onsite check up, you may visit any of SRLs wellness centres in your city at a subsequent date by appointment.’ **End Of Report** Please visit www.srlworld.com for related Test Information for this accession TEST MARKED WITH * ARE OUTSIDE THE NABL ACCREDITED SCOPE OF THE LABORATORY. Dr. Aarti Khanna Nagpal, DNB Senior Pathologist Dr. Shakti Aggarwal,MD Senior Biochemist Dr. Arpita Roy, MD Section Head–Hematology Dr. Chandan Hazarika, M.D Microbiologist Page 4 Of 4